Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

15.75
Delayed Data
As of Dec 09
 +0.55 / +3.62%
Today’s Change
9.59
Today|||52-Week Range
18.75
-8.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues55.4M47.2M52.0M57.9M
 
 
 
 
 
Cost of Goods Sold7.9M7.8M5.8M7.8M
 
 
 
 
 
Depreciation And Amortization10.1M15.6M14.5M7.8M
 
 
 
 
 
 
Operating ExpensesGross Income37.3M23.9M31.6M42.3M
 
 
 
 
 
General Expenses25.7M24.2M21.4M20.9M
 
 
 
 
 
Research And Development11.3M14.7M10.9M10.0M
 
 
 
 
 
Total Operating Expenses43.8M47.5M41.7M36.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income11.6M-320.0K10.2M21.4M
 
 
 
 
 
Extraordinary Charge0.00-183.0K-2.6M-8.1M
 
 
 
 
Interest Expense On Debt6.1M6.3M6.0M5.9M
 
 
 
 
 
Other Expenses3.9M-347.0K-2.5M8.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income9.5M-7.1M-883.0K15.5M
 
 
 
 
 
Income Taxes-685.0K-3.0M-51.0K-7.4M
 
 
 
 
 
Net Income10.2M-4.1M-832.0K8.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.9M42.5M42.8M42.8M
 
 
 
 
 
Shares To Calculate EPS Diluted44.3M42.5M42.8M43.4M
 
 
 
 
 
 
Earnings Per ShareEPS$0.23-$0.10-$0.02$0.19
 
 
 
 
 
EPS Diluted$0.23-$0.10-$0.02$0.19